Evaluation of different adjuvants for foot-and-mouth disease vaccine containing all the SAT serotypes

Onderstepoort Journal of Veterinary Research

Volumn 75, Issue 1, 2008, Pages 17-31

  Cloete, M ^a   Dungu, B ^a,b   Van Staden, L I ^a   Ismail Cassim, N ^a   Vosloo, W ^a,c  

^a ONDERSTEPOORT VETERINARY INSTITUTE   (South Africa)

^b Onderstepoort Biological Products   (South Africa)

^c UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Adjuvant; Cattle; Control strategies; Foot and mouth disease; Pigs; South Africa; Vaccines

Indexed keywords

ANIMALIA; BOS; SUIDAE;

EID: 44649186822     PISSN: 00302465     EISSN: None     Source Type: Journal    
DOI: 10.4102/ojvr.v75i1.84     Document Type: Article

References (43)

1. AUCOUTURIER, J., DUPUIS, L. & GANNE, V. 2001. Adjuvants designed for veterinary and human vaccines. Vaccine, 19:2666-2672.
2. BAHNEMANN, H.G. & MESQUITA, J.A. 1987. Oil-adjuvanted vaccine against foot-and-mouth disease. Bulletin Centro Panamericano Fiebre Altosa, 53:25-50.
3. BARNETT, P.V. & CARABIN, H. 2002. A review of emergency foot-and-mouth disease (FMD) vaccines. Vaccine, 20:1505-1514.
4. BARNETT, P.V., COX, S.J., AGGARWAL, N., GERBER, H. & MCCULLOUGH, K.C. 2002. Further studies on the early protective responses of pigs following immunization with high potency foot-and-mouth disease vaccine. Vaccine, 20:3197-3208.
5. 3 formulations. Report of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-mouth Disease, Berne.
6. BARNETT, P.V., KEEL, P., REID, S., ARMSTRONG, R.M., STATHAM, R.J., VOYCE, C., AGGARWAL, N. & COX, S.J. 2004. Evidence that high potency foot-and-mouth disease vaccine inhibits local virus replication and prevents the carrier state in sheep. Vaccine, 22:1221-1232.
7. BARNETT, P.V., PULLEN, L., WILLIAMS, L. & DOEL, T.R. 1996. International bank for foot-and-mouth disease vaccine: assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants. Vaccine, 14:1187-1198.
8. BARNETT, P.V. & STATHAM, R.J. 2002. Stratified and cryogenically stored (SACS) vaccines, a new concept in emergency foot-and-mouth disease vaccine formulation and storage. Vaccine, 20:2060-2064.
9. BARNETT, P.V., STATHAM, R.J., VOSLOO, W. & HAYDON, D.T. 2003. Foot-and-mouth disease vaccine potency testing: determination and statistical validation of a model using a serological approach. Vaccine, 21:3240-3248.
10. BRÜCKNER, G.K., VOSLOO, W., DU PLESSIS, B.J.A., KLOECK, P.E.L.G., CONNOWAY, L., EKRON, M.D., WEAVER, D.B., DICKASON, C.J., SCHREUDER, F.J., MARAIS., T. & MOGAJANE, E. 2002. Foot-and-mouth disease: the experience of South Africa. Revue Scientifique et Technique, 21:751-764.
11. BRÜCKNER, G.K., VOSLOO, W., CLOETE, M., DUNGU, B. & DU PLESSIS, B.J. 2004. Foot-and-mouth disease control using vaccination: South African experience. Developmental Biology, 119:51-62.
12. + T-cell responses to foot-and-mouth disease virus. Journal of General Virology, 80:663-669.
13. COTTRAL, G.E. 1972a. Foot-and-mouth disease virus neutralization test cross reactions. Bulletin Office International des Epizooties, 77:1239-1261.
14. th Annual Meeting of the US Animal Health Association: 194-207.
15. COX, S.J., BARNETT, P.V., DANI, P. & SALT, J.S. 1999. Emergency vaccination of sheep against foot-and-mouth disease: protection against disease and reduction in contact transmission. Vaccine, 17:1858-1868.
16. COX, J.C. & COULTER, A.R. 1997. Adjuvants - a classification and review of their modes of action. Vaccine, 15:248-256.
17. COX, S.J., VOYCE, C., PARIDA, S., REID, S.M., HAMBLIN, P.A., PATON, D. & BARNETT, P.V. 2005. Protection against direct-contact challenge following emergency FMD vaccination of cattle and the effect of virus secretion of the oropharynx. Vaccine, 23:1106-1113.
18. COX, S.J., VOYCE, C., PARIDA, S., REID, S.M., HAMBLIN, P.A., HUTCHINGS, D., PATON, D. & BARNETT, P.V. 2006. Effect of emergency FMD vaccine payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle. Vaccine, 24:3184-3190.
19. DE LEEUW, P.W., TIESSINK, J.W.A. & VAN BEKKUM, J.G. 1979. The challenge of vaccinated pigs with foot-and-mouth disease virus. Zentralblatt für Veterinärmedizin, 26:98-109.
20. DORA, J.F.P., COELHO NUNES, J.C., GOULAR DE SILVEIRA, J.C., JORGENS, E.N., ROSENBERG, J.F. & ASTUDILLO, V.M. 1984. Epidemic of foot-and-and-mouth disease in Bage, R.S., Brazil, 1980: Evaluation of two systems of vaccination. Bulletin Centro Panamericano Fiebre Altosa, 49-50:11-17.
21. EBLÉ, P.L., BOUMA, A., DE BRUIN, M.G.M., VAN HEMERT-KLUITENBERG, F., VAN OIRSCHOT, J.T. & DEKKER, A. 2004. Vaccination of pigs two weeks before infection significantly reduces transmission of foot-and-mouth disease virus. Vaccine, 22:1372-1378.
22. EBLÉ, P.L., DE BRUIN, M.G.M., BOUMA, A. VAN HEMERT-KLUITENBERG, F. & DEKKER, A. 2006. Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs. Vaccine, 24:1274-1281.
23. EBLÉ, P.L., BOUMA, A., WEERDMEESTER, K., STEGEMAN, J.A., & DEKKER, A. 2007. Serological and mucosal immune responses after vaccination and infection with FMDV in pigs. Vaccine, 25:1043-1054.
24. GOLDE, W.T., PACHECO, J.M., DUQUE, H., DOEL, T., PENFOLD, B., FERMAN, G.S., GREGG, D.R. & RODRIQUEZ, L.L. 2005. Vaccination against foot-and-mouth disease confers complete protection in 7 days and partial protection in 4 days: Use in emergency outbreak response. Vaccine, 23:5775-5782.
25. HAMBLIN, C., BARNETT, I.T. & HEDGER, R.S.A. 1986. A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. I. Development and method of ELISA. Journal of Immunological Methods, 93:115-121.
26. HUNTER, P. 1996. The performance of southern African territories serotypes of foot-and-mouth disease antigen in oil-adjuvanted vaccines. Revue Scientifique et Technique, 15:913-922.
27. HUNTER, P. 1998. Vaccination as a means of control of foot-and-mouth disease in sub-Saharan Africa. Vaccine, 16:261-264.
28. IYER, A.V., GHOSH, S., SINGH, S.V. & DESHMUKH, R.A. 2001. Evaluation of three ready to formulate oil adjuvants for foot-and-mouth disease vaccine production. Vaccine, 19:1097-1105.
29. KITCHING, R.P., BARNETT, P.V. & DONALDSON, A.I. 2000. Foot-and-mouth disease, in Manual of standards for diagnostic tests and vaccines, edited by OIE Biological Standards Committee. Paris: OIE
30. PATIL, P.K., BAYRY, J., RAMAKRISHNA, C., HUGAR, B., MISRA, L.D. & NATARAJAN, C. 2002a. Immune responses of goats to foot-and-mouth disease quadrivalent vaccine: comparison of double-oil emulsion and aluminium hydroxide gel vaccines in eliciting immunity. Vaccine, 20:2781-2789.
31. PATIL, P.K., BAYRY, J., RAMAKRISHNA, C., HUGAR, B., MISRA, L.D., PRABHUDAS, K. & NATARAJAN, C. 2002b. Immune responses of sheep to foot-and-mouth disease quadrivalent vaccine: rate of development of immunity and variations among other ruminants. Journal of Clinical Microbiology, 40:4367-4371.
32. th ed. (Introduction). VSA International.
33. QUATTROCCHI, V., BIANCO, V., FONDEVILA, N., PAPPALARDO, S., SADIRA, A. & ZAMORANO, P. 2004. Use of new adjuvants in an emergency vaccine against foot-and-mouth disease virus: evaluation of conferred immunity. Control of Infectious Animal Diseases by Vaccination, Developmental Biology, 119:481-497.
34. QUATTROCCHI, V., FONDEVILA, N., PAPPALARDO, S., SADIRA, A. & ZAMORANO, P. 2006. Development of an adjuvanted vaccine with rapid delivery against foot-and-mouth disease virus (FMDV). The Third International Workshop on Vaccine Adjuvants and Glycoconjugates, Varadero, Cuba, April 16-20, 2006.
35. RWEYEMAMU, M.M., BOOTH, J.C., HEAD, M. & PAY, T.W.F. 1978. Microneutralization tests for serological typing and subtyping of foot-and-mouth disease virus strains. Journal of Hygiene (London), 81:107-123.
36. SMITSAART, E., ESPONOZA, A.M., SANGUINETTI, R., FILIPPI, J., HAM, A. & BELUNZONI, R. 2004. Addition of saponin to double oil emulsion FMD vaccines enhances specific antibody responses in cattle and pigs. Report on the European Commission for the control of foot-and-mouth disease. Session of the Research Group of the Technical Standing Committee, Food and Agriculture Organization of the United Nations, Chania, Greece, 11-15 October 2004: 344-351.
37. SMITSAART, E., MATTION, N., FILIPPI, J.L., ROBIOLO, B., PERIOLO, O., LA TORRE, J. & BELLINZONI, R.C. 2000. Enhancement of the immune response induced by the inclusion of saponin in oil adjuvanted vaccines against foot-and-mouth disease. Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of FMD. Borovets, Bulgaria (Appendix), 32:255-262.
38. th ed. Ames: Iowa State University Press.
39. STELLMANN, C. TERR, J., FAVRE, H., BRUN, A. & FONTAINE, J. 1977. Comparison of foot-and-mouth disease vaccine potency in terms of the nature of the diluent. Archives of Virology, 54:61-74.
40. SUTMOLLER, P., BARTELING, S.S., OLASCOAGA, R.C. & SUMPTION, K.J. 2003. Control and eradication of foot-and-mouth disease. Virus Research, 91:10-144.
41. VAN BEKKUM, J.G., BOOL, P.H. & VERMEULEN, C.J. 1967. Experience with the vaccination of pigs for the control of foot-and-mouth disease in the Netherlands. Tijdschrift voor Diergeneeskunde, 92:87-97.
42. VOSLOO, W., BASTOS, A.D.S., SANGARE, O., HARGREAVES, S.K. & THOMSON, G.R. 2002a. Review of the status and control of foot-and-mouth disease in sub-Saharan Africa. Revue Scientifique et Technique, 21:437-449.
43. VOSLOO, W., BOSHOFF, K., DWARKA, R. & BASTOS, A. 2002b. The possible role that buffalo played in the recent outbreaks of foot-and-mouth disease in South Africa. Annals of the New York Academy of Sciences, 969:187-190.